← Leaderboards
Balu Easwaramoorthy
Sloan-Kettering Inst Can Research
$752,454
Attributed
$1,690,135
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $575.5K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$1,690,135 · 1
By mechanism
R01$1,690,135 · 1
Top collaborators
- Joseph Reginald Osborne3 shared
- Wolfgang Weber1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jason S Lewis$26,024,327
- Jan Grimm$17,140,928
- Pat B Zanzonico$6,736,096
- Nagavarakishore Pillarsetty$8,324,037
- Quathek Querfelli$1,604,594
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectCountryAntigen BindingAffinityAustraliaAnimal ModelBiodistributionBiologicalAsiansCationsCell Culture TechniquesChromatographyClinicBaseClinical ResearchClinical Research SiteClinical TrialsCollaborationsCommercializationCongressesCostCost EffectiveCost EfficientCyclotrons
Grant awards (3)
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use$575,548
R01 · FY2018 · CA
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use$558,907
R01 · FY2017 · CA
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use$555,680
R01 · FY2016 · CA